BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2018
View Archived Issues
Autoantibodies contribute to memory dysfunction
Read More
Early diagnosis of gestational diabetes
Read More
Release of safety and efficacy data of pinometostat for the treatment of acute advanced leukemia
Read More
Preclinical identification of a potential druggable target for chronic kidney disease
Read More
Dissemination of data from four phase I studies GSK-2838232, a second-generation drug for HIV
Read More
Sunitinib noninferior to nephrectomy in patients with metastatic renal-cell carcinoma
Read More
Potential new anti-obesity target identified
Read More
GT Biopharma initiates OXS-1550 combination study with a multi billion dollar oncology drug
Read More
Biogen describes new mitogen-activated protein kinase kinase kinase 5 inhibitors
Read More
TGF-beta decoy receptors patented by Tessa Therapeutics
Read More
Inovelon receives marketing authorisation extension in Europe
Read More
Updated data presented from long-term extension phase Ib study of aducanumab
Read More
First patient dosed in phase III study of ZL-2306 in SCLC
Read More
Positive topline data presented from phase Ib study of TAR-302 in idiopathic overactive bladder
Read More
AZD-5718: an oral FLAP inhibitor for the treatment of CAD
Read More
Development of a new PAM for the treatment of Parkinson's disease
Read More
Gradalis initiates phase III study of Vigil in Ewing's sarcoma
Read More
Clinical trials completed for Celltrion's Remsima SC
Read More